Apex Farms Corp. Launches its Reg A+ IPO

New York, NY — September 21, 2018 — /D.M.O. Newswire/ – Apex Farms Corp., a vertical farming technology company that designs and produces proprietary vertical hydroponic farming systems for both commercial and residential use, announced that its offering statement has been qualified by the Securities and Exchange Commission, or SEC, pursuant to the Regulation A+ Tier 2 framework, which is open to both accredited and non-accredited investors. Apex Farms also intends to work with a market maker following the final closing of the offering to file an application with the Financial Industry Regulatory Authority, or FINRA, under Rule 15c2-11 to have its securities quoted on the over-the-counter market.

Apex Farms Corp. is seeking to sell up to 5,000,000 shares of its common stock at an offering price of $0.20 per share for aggregate maximum gross proceeds of one million dollars ($1,000,000). The Company intends to use the net proceeds for engineering and prototyping, marketing, production and inventory, administrative and corporate expenses, professional fees and compensation and working capital reserves.

To learn more about the offering, click here.  To learn more about Apex Farms, click here.

Important Notice the Regarding Regulation A Offering

An offering statement regarding the offering described above has been filed with the SEC. The SEC has qualified that offering statement, which means that Apex Farms Corp. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement through this link. 
 
Investing in an initial public offering like our Regulation A offering is subject to unique risks, tolerance for volatility, and potential loss of your investment, that investors should be aware of prior to making an investment decision.   Please carefully review the risk factors contained in the offering circular for this offering.